Search
for
Sort by
Research 91–120 of 1000+
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- Two Birds that Exclude Each Other: The Renbök Phenomenon
- Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- SnapshotDx Quiz: September 2018
- Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients
- Experience in treating multifocal alopecia areata in a child with Jak kinase inhibitors
- New Treatment Strategies in Management of Alopecia Areata: Review Article
- A Novel Hope for Alopecia Totalis Patients: Case Report
- High throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in Alopecia Areata
- Treatment of Alopecia Areata With Tofacitinib
- Therapeutic synergy between contact dermatitis from a wig‐fixing device and tofacitinib on alopecia areata
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Rapidly Progressive Alopecia Universalis after Varicella-Zoster Virus Infection: The role of Immune Dysregulation and Tofacitinib treatment
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- Alopecia areata: from pathophysiology to therapeutic innovation
- A Case of Tofacitinib for the Treatment of Resistant Vitiligo and Sustained Repigmentation After Discontinuation
- Successful treatment of resistant alopecia totalis with tofacitinib
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata
- Supplementary Material for: Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- Sequential small-molecule therapy for lymphocytic cicatricial alopecia: A multicenter prospective cohort pilot study
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib